MOORE ALISON

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$12.63M

Insider Activity of MOORE ALISON

The largest sale of all time was on 2019-06-03 and amounted to 97656 shares of Allogene Therapeutics, Inc. for $2.61M.

Biography of MOORE ALISON

No biography is available at this moment.

2022-03-15SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
8,698
0.006%
$7.63$66,388+21.54%
2021-03-15SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
6,164
0.0046%
$38.14$235,089-42.72%
2020-10-13SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
11,031
0.0082%
$42.00$463,302-35.64%
2020-10-09SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
39,509
0.03%
$41.00$1.62M-32.47%
2020-10-08SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
5,065
0.004%
$41.00$207,665-30.48%
2020-10-06SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
44,574
0.035%
$40.00$1.78M-27.81%
2020-03-16SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
7,500
0.0072%
$19.19$143,960+88.77%
2019-09-18SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
42,134
0.0405%
$32.13$1.35M-14.57%
2019-09-17SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
45,006
0.0442%
$32.11$1.45M-12.57%
2019-09-16SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
10,514
0.0055%
$17.14$180,167-12.57%
2019-07-30SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
23,638
0.0226%
$29.84$705,476-9.72%
2019-07-29SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
47,630
0.0463%
$29.39$1.4M-6.76%
2019-07-26SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
26,386
0.0138%
$15.73$414,942-6.06%
2019-06-03SaleAllogene Therapeutics, Inc.
ALLO
Chief Technical Officer
97,656
0.0961%
$26.76$2.61M-0.59%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.